Antiaging Quantum Living files Form 12b-25 notice
Antiaging Quantum Living Inc. notified the SEC that it could not timely file its Annual Report on Form 10-K for the fiscal year ended March 31, 2026 by the June 29, 2026 due date due to a delay completing the Annual Report's financial statements.
Rhea-AI Filing Summary
Antiaging Quantum Living Inc. notified the SEC that it could not timely file its Annual Report on Form 10-K for the fiscal year ended March 31, 2026 by the June 29, 2026 due date due to a delay completing the Annual Report's financial statements. The company states it anticipates filing the Annual Report no later than the fifteenth calendar day following the prescribed filing date.
Positive
- None.
Negative
- None.
Insights
Late 10-K filing flagged with a 12b-25 cure window.
The filing documents a procedural delay in completing financial statements for the fiscal year ended March 31, 2026 and invokes Rule 12b-25 relief. The company explicitly anticipates filing within the fifteen-calendar-day cure period.
Key dependencies include completion and review of audited financials and any accountant statements; subsequent filings will show whether the cure occurred within the stated window.
Key Figures
Key Terms
Rule 12b-25 regulatory
Form 10-K financial
smaller reporting companies regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did Antiaging Quantum Living (AAQL) file a Form 12b-25?
When does AAQL expect to file the delayed Form 10-K?
Does the Form 12b-25 say whether other periodic reports are current for AAQL?
Who signed the Form 12b-25 for AAQL and when was it signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.